“`html
Three dividend stocks recommended by Motley Fool contributors include AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). AbbVie has a forward yield of over 3.5% and boasts a record of 53 consecutive annual payout increases. Bristol Myers’ current yield is 5.1%, backed by $13.1 billion in free cash flow over the past year. Pfizer offers a higher yield of 7.38%, although its payout ratio stands at 122.5%. Despite this, its free cash flow is expected to rise due to cost-cutting measures.
AbbVie leads with growth from its immunology drugs, expected to generate more than $31 billion by 2027. Bristol Myers is seeing 18% growth in its non-legacy products, and recent approvals potentially signal a bright future. Pfizer is focusing on new products and maintaining a solid pipeline despite recent setbacks.
“`
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
